Our results indicated that treatment of ASE obviously declined the serum levels of IL-1β, TNF-α, IL-6 and MCP-1, implying the anti-RA effect of ASE was partially via the inhibition of pro-inflammatory cytokines in CFA-induced RA rats. The gene discussed is CCL2; the disease is rheumatoid arthritis.